Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study

INTRODUCTION: The REWIND study demonstrated a cardiovascular (CV) benefit of dulaglutide treatment in patients with type 2 diabetes (T2D) with or without established cardiovascular disease (CVD). The current study aims to describe similarities and differences between characteristics of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dib, Anne, Chartier, Florence, Ihle, Katharina, Jamonneau, Isabelle, Ludwig, Lisa, Darmon, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873332/
https://www.ncbi.nlm.nih.gov/pubmed/35034340
http://dx.doi.org/10.1007/s13300-021-01200-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873332/
https://www.ncbi.nlm.nih.gov/pubmed/35034340
http://dx.doi.org/10.1007/s13300-021-01200-0

Ejemplares similares